Containing Or Obtained From Panax Or Acanthopanax (e.g., Ginseng, Etc.) Patents (Class 424/728)
-
Patent number: 7081259Abstract: The present invention relates to an extract having healing activity on injuries, which is obtained by extracting Astragali Radix, Ginseng Radix, Carthami Flos, Angelicae Gigantis Radix, Cnidii Rhizoma, Rehmanniae Radix Preparata, Paeoniae Radix and Cinnamomi Cortex Spissus with water while heating, and a pharmaceutical composition for treating injuries, a health food for post-surgical recovery and an animal feed containing said extract as the active ingredient.Type: GrantFiled: February 20, 2002Date of Patent: July 25, 2006Assignees: Healthy & Happy Co., Ltd.Inventor: Jong-Soo Hong
-
Patent number: 7081258Abstract: The present invention relates to a composition for promoting hair growth. More particularly, the present invention comprises a component for inhibiting 5?-reductase activity, a functional component of cell activity, and an expansion component of peripheral blood vessels. A composition for promoting hair growth of the present invention has a superior effect on hair growth.Type: GrantFiled: September 28, 2001Date of Patent: July 25, 2006Assignee: LG Household & Health Care Ltd.Inventors: Seong-Lok Hwang, In-Byeong Yoon, Min-Ho Lee, Sug-Youn Chang, Moon-Jeong Rang, Ho-Jeong Ahn
-
Patent number: 7074440Abstract: The present invention relates to herbal compositions and methods for regulating body weight, especially for promoting body weight loss, for maintaining or controlling body weight, reducing blood levels of circulating chemical fuels (e.g., glucose, carbohydrates, fatty acids, and cholesterol), facilitating or promoting metabolism, treating diabetes, treating body weight disorders, and the like.Type: GrantFiled: February 26, 2003Date of Patent: July 11, 2006Inventor: Rulin Xiu
-
Patent number: 7067160Abstract: This invention is directed towards processes of making fractions from North American ginseng and to compositions containing these fractions. This invention is also directed towards methods of methods of preparing pharmaceuticals containing these fractions. Additionally, this invention is directed towards methods of stimulating the production of immunoglobins by administering fractions of this invention and also to methods of activating B-lymphocyte proliferation and antibody production by administering fractions of this invention. This invention is also directed towards a method of stimulating the production of IL-16, IL-1, and/or TNF-? in cells by administering a fraction of this invention.Type: GrantFiled: July 2, 2002Date of Patent: June 27, 2006Assignee: C V Technologies Inc.Inventors: Jacqueline J. Shan, Peter K. T. Pang, Buhan Huang, Lei Ling
-
Patent number: 7060726Abstract: Provided is an antibacterial agent exhibiting an excellent antibacterial activity effect and exerting a mild influence on the environment and humans. The antibacterial agent of the present invention comprises, as an effective component, a mixture of coumarin analogues extracted from a citrus fruit pericarp, particularly a mixture of coumarin analogues obtained from citrus cold press oil.Type: GrantFiled: March 30, 2004Date of Patent: June 13, 2006Assignee: Takasago International CorporationInventors: Tadahiro Hiramoto, Ryo Takeuchi, Minoru Hanada, Ritsuko Norose, legal representative, Fumitaka Norose, deceased
-
Patent number: 7005147Abstract: A fatigue recovery medicine for changing in hepatic mRNA levels of stress-related genes is disclosed. The fatigue recovery medicine for changing in hepatic mRNA levels of stress-related genes is composed of: astragali radix of 13.2% by weight, atractylodis rhizoma alba of 8.8% by weight, angelicae gigantis radix of 8.8% by weight, longanae arillus of 8.8% by weight, lycii folium of 8.8% by weight, cridii rhizoma of 6.7% by weight, hoellen of 4.4% by weight, glycyrrhizae radix of 4.4% by weight, carthami flos of 4.4% by weight, cervi parvum cornu of 4.4% by weight, crataegi fructus of 4.4% by weight, rehmanniae radix preparata of 4.4% by weight, saussureae radix of 4.4% by weight, amomi fructus of 4.4% by weight, polygony multiflori radix of 4.4% by weight, paeoniae radix alba of 4.4% by weight and ginseng radix of 4.4% by weight.Type: GrantFiled: August 22, 2002Date of Patent: February 28, 2006Inventor: Jun-Sik Shin
-
Patent number: 6991815Abstract: The invention discloses a pharmaceutical composition for preventing and/or treating peptic ulcer, including American ginseng or the extract thereof, and a method for preparing American ginseng extract, said method including extracting American ginseng with water or ethanol aqueous solution, and then ultrafiltrating, dialyzing, precipitating with ethanol, or performing reverse phase chromatography to obtain various fractions of extract with anti-peptic ulcer effect.Type: GrantFiled: May 20, 2004Date of Patent: January 31, 2006Assignee: Medical and Pharmaceutical Industry Technology and Development CenterInventors: Feng-Nien Ko, Chien-Jen Shih, Je-Yie Lin, Pey-Chyi Wu, Mo-Chi Cheng
-
Patent number: 6969533Abstract: The invention is a beverage involving an ingestible fluid and a dosage amount of an ingestible composition for treating an inflammatory tissue in a mammal, involving the inflammatory tissue selected from the group comprising underperfused tissue, inflamed joints, inflamed muscles, wherein the dosage amount has a glucose ingredient, such as glucosamine sulfate, glucosamine hydrochloride, n-acetyl glucosamine, and combinations thereof; a chondroitin component, such as chondroitin sulfate, chondroitin hydrochloride, and combinations thereof; a member of the family of araliaceae for buffering the ingestion of the glucose ingredient, such as American ginseng, Siberian ginseng, panax ginseng, and combinations thereof; a calcium containing component; and a sulfonate having at least one methyl group ingesting the beverage.Type: GrantFiled: July 30, 2003Date of Patent: November 29, 2005Inventors: Kenneth A. Martin, Teresa Leigh Barr
-
Patent number: 6962719Abstract: The invention discloses a pharmaceutical composition for preventing and/or treating peptic ulcer, including American ginseng or the extract thereof, and a method for preparing American ginseng extract, said method including extracting American ginseng with water or ethanol aqueous solution, and then ultrafiltrating, dialyzing, precipitating with ethanol, or performing reverse phase chromatography to obtain various fractions of extract with anti-peptic ulcer effect.Type: GrantFiled: March 9, 2000Date of Patent: November 8, 2005Assignee: Pharmaceutical Industry Technology and Development CenterInventors: Feng-Nien Ko, Chien-Jen Shih, Je-Yie Lin, Pey-Chyi Wu, Mo-Chi Cheng
-
Patent number: 6953580Abstract: The present invention provides a composition containing an extract from Wisteria floribunda, Myristica fragrans, Punica granatum, Trapa bispinosa or a derivative thereof, Coix lachiryma-jobi, Elfvingia applanata and Ganoderma lucidum or a derivative thereof (optionally further containing Panax ginseng or Panax japonicus), which has a superior antiviral activity, a superior peripheral blood flow-improving activity and a superior hair growth-stimulating activity, and a production method thereof.Type: GrantFiled: July 24, 2002Date of Patent: October 11, 2005Assignee: Nitto Denko CorporationInventors: Hozumi Tanaka, Ken Hibino, Yasuyo Hijikata
-
Patent number: 6949523Abstract: This invention relates to a group of novel sapogenins, their use in anti-cancer applications, and to a process for their production. More particularly, this invention pertains to a novel group of dammarane sapogenins, PAM-120, PBM-110 and PBM-100 (the dammarance sapogenine structure is specifically clean of any sugar moieties (glycons) at any position and hydroxyl at C-20) and PAN-20 and PAN-30 (the dammarance sapogenin structure has sugar moieties but is free of hydroxyl at C-20), obtained by chemical cleavage of dammarane saponins. The invention also includes a novel application of the said sapogenins for anti-cancer treatment by using them separately or together, and/or jointly with other drugs, as well as to the process of producing these novel sapogenins. Said novel dammarane sapogenins show surprising anti-cancer effect when applied, particularly against multi-drug resistant cancers.Type: GrantFiled: July 24, 2001Date of Patent: September 27, 2005Assignee: Panagin Pharmaceuticals, Inc.Inventors: Dong Huang, Dong Feng Qi
-
Patent number: 6936283Abstract: A stable composition preferably a refreshing drink for accelerating degradation of alcohol and acetaldehyde in the body, comprises synergistic combination of caffeine, herbs and fructose. Preferably, the composition comprises, Caffeine, Guaranà caffeine, Yerba Matè, Eleutherococcus senticous, Panax ginseng, ginger, Glycyrrhiza glabra (Liquorice Root), fructose and additional ingredients (sugars, flavourings, colourings, vitamins, stabilisers, whole fruit powder and the like), and optionally ginkgo biloba.Type: GrantFiled: July 25, 2003Date of Patent: August 30, 2005Inventor: Bjørn T. Langeland
-
Patent number: 6933291Abstract: The invention provides a composition and a method for lowering blood serum cholesterol levels or for preventing elevated blood serum cholesterol levels, as well as suitable composition comprising (a) one or more phytosterols and/orphytostanols or a mixture thereof capable of reducing cholesterol absorption in the intestine, (b) a composition capable of inhibiting cholesterol biosynthesis, and (c) a composition capable of increasing cholesterol metabolism, wherein at least one of compositions b. and c. is preferably derived from plants.Type: GrantFiled: December 1, 2000Date of Patent: August 23, 2005Assignee: N.V. NutriciaInventors: Chen Qi, Hendricus Bartholomeus Andreas De Bont, Luutsche Van Der Zee, Mirian Lansink, Klaske Van Norren
-
Patent number: 6911221Abstract: A unique class of anti-neoplastic compositions are described. The compositions contain certain Chinese medicinal herbs: Panax ginsing, Poria cocos, Atractylodes macrocephala, Angelic sinensis, Astragalus membranaceus, Curcuma zedoaria, Scutellaria baicalensis, Coptis chinenisis, Glycyrrhiza uralenisis, Crataegus pinatifida, Hordeum vulgare, Schisandra chinensis, Hedyotis diffusa, Ophiophogon japonicus, and Lobelia chinesis lour. Extensive testing indicates an effective treatment rate of 69.7% and 84.3% when used in combination with radiotherapy or chemotherapy. The animal trials conducted demonstrate that the anti-neoplastic compositions increase the activity of NK cells, and reduce and prevent metastasis of tumors under stress conditions.Type: GrantFiled: November 1, 2001Date of Patent: June 28, 2005Inventor: Hongfen Li
-
Patent number: 6905712Abstract: A composition, which includes ingredients capable of enhancing the immunogenic effect of a vaccine, includes an aluminium salt and at least one ginsenoside, such as a tri-terpenoid glycoside, preferably a tri-terpenoid glycoside of the structure of Rb1. In one particular embodiment, the aluminium salt is Al(OH)3. A kit for use as adjuvant or co-adjuvant of an immunogenic composition includes the composition. The use of such a tri-terpenoid glycoside in the manufacture of a pharmaceutical preparation enhanced the immunogenic effect of a vaccine. A pharmaceutical preparation includes the composition and an aluminium salt, such as Al(OH)3 and a pharmaceutically acceptable carrier.Type: GrantFiled: December 8, 2000Date of Patent: June 14, 2005Assignee: Statens Veterinarmedicinska AnstaltInventor: Esteban Rivera Vega
-
Patent number: 6899902Abstract: The present invention relates to dietary fibers and oligosaccharides from Ginseng and process for preparation thereof, more particularly, to a method of preparing the dietary fiber from Ginseng by extruding and centrifuging byproducts from Ginseng extract, in the meantime, preparing the oligosaccharides from Ginseng by treating byproducts from Ginseng extract with polysaccharides hydrolytic enzymes and the subsequent ultrafiltration. Thus it provides prominent effects in producing physiologically active materials such as the dietary fibers and oligosaccharides from the said byproducts in an environment-friendly manner.Type: GrantFiled: October 9, 2001Date of Patent: May 31, 2005Assignee: Yonsei UniversityInventor: Jaekwan Hwang
-
Patent number: 6896910Abstract: Disclosed is an anti-fatigue and nutritious tonic agent containing powder of wild ginseng, optionally in admixture with a herb medicine, or water extract of the powder, which has remarkably enhanced anti-fatigue, and nutrition and tonic effects as compared with agents containing cultivated ginseng.Type: GrantFiled: January 25, 2002Date of Patent: May 24, 2005Inventors: Won Kyu Kim, Kye Won Lee, Sun Jung Lee, Bong Jun Kim, Hye Young Lee, Chul Hong Park, Dong Soo Kim, Kyeong Bum Choi, Eun Joung Yoo
-
Patent number: 6897298Abstract: This invention discloses a compound (I) of the following formula. This invention also includes a method for extracting the compound (I), and a pharmaceutical composition containing the compound (I). The extracting method includes the following steps: taking the corpus radicis and/or radix fibrosa of a ginseng spp. plant—ginseng or pseudo-ginseng, extracting with industrial alcohol and n-butanol to extract the total saponins, and then purifying by silicon gel column chromatography and reversed phase column chromatography to obtain the compound (I). The compound (I) and pharmaceutical composition can be used to cure acute ischemic cerebral-vascular diseases.Type: GrantFiled: January 3, 2001Date of Patent: May 24, 2005Assignees: Guangdong Taihe Biopharmaceutical Co., Ltd., Dept. of Science & Tech DevelopInventors: Yongyuan Guan, Fulin Fan
-
Patent number: 6855346Abstract: The present invention provides a method for treating patients with liver diseases by co-administrating a pharmaceutical composition and lamivudine to the patients. The pharmaceutical composition is a herbal mixture which contains, as the core ingredients, the aqueous extracts of the entire plant of Herba Hedyotidis diffusae, the rhizome of Rhizoma Bistortae, the rhizome of Rhizoma Polygoni Cuspidati, and the ripe fruit of Fructus Schisandrae. The present invention also provides methods for preventing a relapse of hepatitis in patients after the lamivudine treatment has been discontinued and for suppressing the development of lamivudine drug resistance in patients by providing the lamivudine-treated patients with the pharmaceutical composition of the present invention.Type: GrantFiled: July 11, 2002Date of Patent: February 15, 2005Inventor: Tzu-Sheng Wu
-
Publication number: 20040247703Abstract: Disclosed is a composition for inhibiting glutamate-mediated neurotoxicity comprising 20(S)-ginsenoside Rg3, 20(S)-ginsenoside Rh2 or the mixture of 20(S)-ginsenoside Rg3 and 20(S)-ginsenoside Rh2. The composition of the present invention has an excellent neurotoxicity inhibition effect or nerve cell protection effect. Accordingly, it can be effectively used for treating nervous diseases including cerebral trauma, cerebral apoplexy, cerebral hemorrhage; epilepsy occurred by excessive activation of glutamate receptors; or Huntington's disease.Type: ApplicationFiled: October 27, 2003Publication date: December 9, 2004Inventors: Hyewhon Rhim, Sunoh Kim
-
Publication number: 20040234626Abstract: Food supplement compositions and their methods of use in increasing lean mass and/or muscle size and/or strength in individuals, particularly, athletes is described. The food supplements described comprise a substance which increases nitric oxide production in the body, and, a source of amino acids. Other food supplements described comprise a substance which can enhance and/or mimic insulin activity, and a source of amino acids. The food supplement compositions described are suitable for supplementing the diet of an athlete and particularly for enhancing an athlete's muscle size or strength.Type: ApplicationFiled: June 22, 2004Publication date: November 25, 2004Inventors: Paul T. Gardiner, Derek E. Woodgate, Mark S. Gilbert, Robert W. Thoburn
-
Publication number: 20040234627Abstract: The present invention provides an herbal pharmaceutical compositions comprising the root of scutellaria, the rhizome of coptis, the root and rhizome of rhubarb, and the dry powders of the root of ginseng (or American ginseng) or the rhizome of ginger. The herbal pharmaceutical compositions are effective in preventing patients from developing or treating patients with cardiovascular diseases, which include, but are not limited to, hypertension, coronary heart disease, cerebrovascular disease, peripheral vascular disease, heart failure, rheumatic heart disease, congenital heart disease, and cardiomyopathies. The present invention also provides methods for preparing and using the herbal pharmaceutical compositions.Type: ApplicationFiled: June 25, 2004Publication date: November 25, 2004Applicants: SunTen Pharmaceutical Co., Ltd.Inventors: Shuenn-Jyi Sheu, Chung Guang Shen
-
Publication number: 20040234544Abstract: The invention concerns a formulation containing phosphatidylserine (PS) and/or lyso-phosphatidylserine for preventing and treating mental and physical stress states, where the phosphatidylserine is, among others, combined with plant extracts or essences. Daily doses of 50 to 1000 mg PS are envisaged within the scope of the present invention which are administered over a maximum period of six months. Preferred subjects are humans of 10 to 50 years of age.Type: ApplicationFiled: February 6, 2004Publication date: November 25, 2004Inventors: Ralf Jager, Bokenkamp Dirk
-
Publication number: 20040213860Abstract: The invention discloses a pharmaceutical composition for preventing and/or treating peptic ulcer, including American ginseng or the extract thereof, and a method for preparing American ginseng extract, said method including extracting American ginseng with water or ethanol aqueous solution, and then ultrafiltrating, dialyzing, precipitating with ethanol, or performing reverse phase chromatography to obtain various fractions of extract with anti-peptic ulcer effect.Type: ApplicationFiled: May 20, 2004Publication date: October 28, 2004Applicant: Pharmaceutical Industry Technology and Development Center, a Taiwan corporationInventors: Feng-Nien Ko, Chien-Jen Shih, Je-Yie Lin, Pey-Chyi Wu, Mo-Chi Cheng
-
Publication number: 20040208942Abstract: Food supplement compositions and their methods of use in increasing lean mass and/or muscle size and/or strength in individuals, particularly, athletes is described. The food supplements described comprise &agr; lipoic acid or a derivative thereof, and an amino acid. Other food supplements described comprise a substance which can enhance and/or mimic activity of &agr; lipoic acid, and a source of amino acid. The food supplement compositions described are suitable for supplementing the diet of an athlete and particularly for enhancing an athlete's muscle size and/or strength.Type: ApplicationFiled: May 7, 2004Publication date: October 21, 2004Inventors: Paul Gardiner, Derek Woodgate
-
Publication number: 20040202730Abstract: This invention is related to an improved composition for treating heart conditions. More specifically, the present invention is related to an improved composition for treating heart conditions containing borneol, rosmarinic acid and a ginsenoside selected from the group consisting of ginsenoside Rg1 and ginsenoside Rb1.Type: ApplicationFiled: April 8, 2003Publication date: October 14, 2004Inventors: Robert Gow, John Pierce, Brian Pierce, William Birdsall
-
Publication number: 20040202731Abstract: This invention is related to methods and compositions comprising rosmarinic acid. More specifically, the present invention comprises compositions comprising borneol, rosmarinic acid and at least one ginsenoside.Type: ApplicationFiled: April 5, 2004Publication date: October 14, 2004Inventors: Robert T. Gow, Brian Pierce, John Pierce, William Birdsall
-
Patent number: 6800304Abstract: The invention discloses a pharmaceutical composition for preventing and/or treating peptic ulcer, including American ginseng or the extract thereof, and a method for preparing American ginseng extract, said method including extracting American ginseng with water or ethanol aqueous solution, and then ultrafiltrating, dialyzing, precipitating with ethanol, or performing reverse phase chromatography to obtain various fractions of extract with anti-peptic ulcer effect.Type: GrantFiled: May 6, 2002Date of Patent: October 5, 2004Assignee: Pharmaceutical Industry Technology and Development CenterInventors: Feng-Nien Ko, Chien-Jen Shih, Je-Yie Lin, Pey-Chyi Wu, Mo-Chi Cheng
-
Patent number: 6800292Abstract: This application relates to dermatological agents for treating dermatological disorders. The dermatological agents include a therapeutically effective amount of at least one fruit extract in an amount sufficient to neutralize free radicals, a moisturizing agent in an amount sufficient to facilitate hydration of the skin, and a pharmaceutically acceptable carrier. Preferred fruit extracts include extracts from apricots, apples, peaches, pears, pineapples, papayas, pomegranates, cherries, kiwis, tangerines, grapes, and oranges. The most preferred extract is extract from pomegranate.Type: GrantFiled: February 10, 2000Date of Patent: October 5, 2004Inventor: Howard Murad
-
Publication number: 20040185118Abstract: An innovative health food for good sleepy is provided for improving the factors that interfere with sleep as much as possible and is suitable for attaining good sleep and deep sleep mainly comprising herbal medicines in combination. The health food for good sleep contains a Panax ginseng extract, a Ginkgo biloba leaf extract, a Ganoderma lucidum extract, and calcium, which are mixed together in predetermined proportions. For example, the mixture contains 0.5 to 1.0 parts by weight of the Ginkgo biloba leaf extract, 0.1 to 0.5 parts by weight of the Ganoderma lucidum extract, and 0.1 to 1.0 parts by weight of calcium with respect to 1 part by weight of the Panax ginseng extract.Type: ApplicationFiled: March 19, 2003Publication date: September 23, 2004Inventors: Katsumichi Matsushige, Ryuichi Moriya, Nobuki Muramatsu
-
Publication number: 20040185122Abstract: The present invention is directed toward a method for inhibiting COX-2 in an organism. In particular, the method is preferably directed toward selectively inhibiting COX-2 in an organism. The method comprises the step of administering to the organism an organic extract isolated from an edible plant wherein such extract inhibits COX-2. A method to purify a composition that exhibits COX-2 inhibition and COX-2 selective inhibition from the organic extract is also provided. In addition, a method for treating and/or preventing COX-2 mediated inflammation or inflammation-associated disorders in an organism is provided.Type: ApplicationFiled: April 2, 2004Publication date: September 23, 2004Applicant: Pharmacia CorporationInventors: Mark G. Obukowicz, Susan L. Hummert
-
Patent number: 6793944Abstract: The present invention provides an herbal pharmaceutical composition comprising the root of scutellaria, the rhizome of coptis, the root and rhizome of rhubarb, and the dry powders of the root of ginseng (or American ginseng) or the rhizome of ginger. The herbal pharmaceutical composition is effective in preventing patients from developing or treating patients with cardiovascular diseases, which include, but are not limited to, hypertension, coronary heart disease, cerebrovascular disease, peripheral vascular disease, heart failure, rheumatic heart disease, congenital heart disease, and cardiomyopathies. The present invention also provides methods for preparing and using the herbal pharmaceutical composition.Type: GrantFiled: June 10, 2002Date of Patent: September 21, 2004Assignees: Sun Ten Pharmaceutical Co., Ltd.Inventors: Shuenn-Jyi Sheu, Chung Guang Shen
-
Publication number: 20040180077Abstract: This invention relates to the administration of ingredients which reduce the appetite, promote weight loss and increase energy using rapidly dissolving films or strips. The benefits of the invention may be achieved through a variety of different mechanisms including addition of active ingredients, including ingredients which alter taste, promote satiety and boost energy, to the rapidly dissolving strips.Type: ApplicationFiled: March 5, 2004Publication date: September 16, 2004Inventors: Donald K. Riker, Joseph Czerwinski, Tom Knopp
-
Publication number: 20040175442Abstract: Food supplement compositions and their methods of use in increasing lean mass and/or muscle size and/or strength in individuals, particularly, athletes is described. The food supplements described comprise a substance which increases nitric oxide production in the body, and, a source of amino acids. Other food supplements described comprise a substance which can enhance and/or mimic insulin activity, and a source of amino acids. The food supplement compositions described are suitable for supplementing the diet of an athlete and particularly for enhancing an athlete's muscle size or strength.Type: ApplicationFiled: March 11, 2004Publication date: September 9, 2004Inventors: Paul T. Gardiner, Derek E. Woodgate, Mark S. Gilbert, Robert W. Thoburn
-
Publication number: 20040175443Abstract: Food supplement compositions and their methods of use in increasing lean mass and/or muscle size and/or strength in individuals, particularly, athletes is described. The food supplements described comprise a substance which increases nitric oxide production in the body, and, a source of amino acids. Other food supplements described comprise a substance which can enhance and/or mimic insulin activity, and a source of amino acids. The food supplement compositions described are suitable for supplementing the diet of an athlete and particularly for enhancing an athlete's muscle size or strength.Type: ApplicationFiled: March 11, 2004Publication date: September 9, 2004Inventors: Paul T. Gardiner, Derek E. Woodgate, Mark S. Gilbert, Robert W. Thoburn
-
Patent number: 6784209Abstract: Food supplement compositions and their methods of use in increasing lean mass and/or muscle size and/or strength in individuals, particularly, athletes is described. The food supplements described comprise a substance which increases nitric oxide production in the body, and, a source of amino acids. Other food supplements described comprise a substance which can enhance and/or mimic insulin activity, and a source of amino acids. The food supplement compositions described are suitable for supplementing the diet of an athlete and particularly for enhancing an athlete's muscle size or strength.Type: GrantFiled: January 13, 2000Date of Patent: August 31, 2004Assignee: Muscletech Research and Development Inc.Inventors: Paul T. Gardiner, Derek E. Woodgate, Mark S. Gilbert, Robert W. Thoburn
-
Patent number: 6773729Abstract: A dietary supplement consisting essentially of a combination of Ginseng and Ginkgo to improve the speed of memory and memory quality in normal, healthy subjects and to prevent deterioration of the speed of memory in people with decreased cognitive functions, and to counteract cognitive fatigue.Type: GrantFiled: November 1, 2002Date of Patent: August 10, 2004Assignee: Pharmaton S.A.Inventors: Orlando Petrini, Andrew Scholey
-
Publication number: 20040151781Abstract: Pharmaceutical formulation, its use, and method for its manufacture The present invention relates to a pharmaceutical formulation of a calcium salt and a dry plant extract in the form of a coated tablet, wherein it has a core of at least one dry plant extract, enveloped by at least one coating of at least one calcium salt. The plant extracts for the core may be selected from: Vitex agnus castus (chaste tree); Belamcanda chinensis (leopard lily); Cimicifuga racemosa (black cohosh); Trifolium pratense L. (purple trefoil); Oenothera biennis hom. (primrose); Glycine soja (soy bean); Serenoa repens (saw-palmetto); Urtica dioica (stinging nettle), in particular its root; Cucurbita pepo (pumpkin), in particular its seed; Pygeum africanum; as well as suitable mixtures of these.Type: ApplicationFiled: December 8, 2003Publication date: August 5, 2004Inventor: Michael A Popp
-
Patent number: 6770307Abstract: The invention is directed to a herbal medicinal composition for preventing or treating type II diabetes. The composition is comprised of extracts from Pterocarpus marsupium, Morus alba, Orthosiphon aristatus, Opiophogon japonicus, Rosa rugosa, Commelina communis, Trichosanthis kirilowii and Anemarrhena asphodeloides.Type: GrantFiled: November 29, 2002Date of Patent: August 3, 2004Inventors: Ji-Won Yoon, Hee-Sook Jun
-
Publication number: 20040142045Abstract: A nutritional supplement formulation for the enhancement of blood sugar regulation, prevention and treatment of insulin resistance, prevention and treatment of dysinsulinemia, prevention and treatment of Syndrome X, and reduction of diabetic complications is disclosed. The formulation combines herbs, minerals and vitamins known to reduce insulin resistance with herbs, minerals and vitamins known to reduce blood sugar levels.Type: ApplicationFiled: January 21, 2003Publication date: July 22, 2004Inventors: Dennis H. Harris, Robert C. Martin
-
Publication number: 20040142047Abstract: The present invention relates to a Korean Acanthopanax Senticosus extract, a protein extract and crude protein polysaccharide derived therefrom, and an immuno-regulating composition comprising the same as an ative ingredient and the use thereof, and more particularly to a Korean Acanthopanax Senticosus extract and a protein extract and crude protein polysaccharide derived therefrom, which are have effective in increasing immunity and have superior anti-allergy effects and thus can be used as an active ingredient for functional foods, cosmetics, and pharmaceutical compositions, and as an immuno-regulating compositoin comprising the same as an active ingredient and the use thereof.Type: ApplicationFiled: November 17, 2003Publication date: July 22, 2004Inventors: Taek-Joon Yoon, Kyeong-Ho Lee, Woo-Moon Park, Youn-Chul Kim, Ho-Jin Park
-
Publication number: 20040137087Abstract: The invention is directed to chemical processes of preparing fractions from North American ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.Type: ApplicationFiled: October 23, 2003Publication date: July 15, 2004Applicant: C.V. Technologies, Inc.Inventors: Jacqueline J. Shan, Peter K. T. Pang, Buhan Huang, Lei Ling
-
Patent number: 6753018Abstract: Disclosed are a method for processing Panax spp., comprising the step of steaming Panax spp. under the oxygen-enriched atmosphere and a processed Panax spp. obtained by the method.Type: GrantFiled: February 21, 2002Date of Patent: June 22, 2004Assignee: Ginseng Science Inc.Inventors: Seo-Young Park, Sool-Youn Cho, Il-Ho Park, Yong-Jae Lee, Man-Ki Park, Jeong-Hill Park
-
Publication number: 20040109904Abstract: A unique class of anti-neoplastic compositions are described. The compositions contain certain Chinese medicinal herbs: Panax ginsing, Poria cocos, Atractylodes macrocephala, Angelic sinensis, Astragalus membranaceus, Curcuma zedoaria, Scutellaria baicalensis, Coptis chinenisis, Glycyrrhiza uralenisis, Crataegus pinatifida, Hordeum vulgare, Schisandra chinensis, Hedyotis diffusa, Ophiophogon japonicus, and Lobelia chinesis lour. Extensive testing indicates an effective treatment rate of 69.7% and 84.3% when used in combination with radiotherapy or chemotherapy. The animal trials conducted demonstrate that the anti-neoplastic compositions increase the activity of NK cells, and reduce and prevent metastasis of tumors under stress conditions.Type: ApplicationFiled: January 29, 2004Publication date: June 10, 2004Inventor: Hongfen Li
-
Patent number: 6746675Abstract: Compositions are taught that may comprise active components of one or more types of Basidiomycotina that belong to polyporaceae Basidiomycotina and active components of the root of a plant that belongs to Araliaceae. Such compositions have shown hypoglycemic effects and anti-tumor activity. More preferably, the Basidiomycotina may be Ganoderma Lucidum and/or Coriolus versicolor and the plant that belongs to Araliaceae may be medicinal ginseng, e.g. Panax ginseng and/or Panax japonicus. Preferably, an aqueous solution of the composition has an oxidation-reduction potential of less than about 1230 mV, more preferably less than about 900 mV and most preferably less than about 330 mV. Methods for making such compositions are also taught and may include hot water extraction of the above-mentioned components. Furthermore, methods for treating patients are also taught and include administering a therapeutically effective amount of one or more of the present compositions.Type: GrantFiled: October 21, 2002Date of Patent: June 8, 2004Inventor: Tadashi Goino
-
Publication number: 20040096485Abstract: Disclosed are methods and products such as wet wipes and absorbents capable of providing a skin health benefit when utilized in the intended fashion. More specifically, the products described herein comprise an agent, such as a botanical extract, which is capable of increasing the activity of sphingomyelinase according to a Sphingomyelinase Activity Screening Test and/or decreasing the activity of ceramidase according to a Ceramidase Activity Screening Test. By increasing the activity of sphingomyelinase and/or decreasing the activity of ceramidase, the agents in combination with the products described herein are able to maintain or increase the level of ceramides in the skin leading to improved skin health.Type: ApplicationFiled: November 19, 2002Publication date: May 20, 2004Applicant: Kimberly-Clark Worldwide, Inc.Inventors: David W. Koenig, Jamie Joseph Van Gompel
-
Patent number: 6733797Abstract: The present invention relates to a neurochemical formulation comprising a supplement for improving function of neurons, improving memory and cognitive abilities, and reversing free radical damage caused by aging or neurodegenerative disease. The formulation comprises phosphoesters and antioxidants. Components may have antioxidant properties or enhance properties of other components. The synergistic combinations allow individual component dosages to be reduced, thereby minimizing potential toxicity.Type: GrantFiled: November 15, 2001Date of Patent: May 11, 2004Inventor: William K. Summers
-
Patent number: 6730331Abstract: The present invention is a stable topical creatine application suitable for absorption directly through the skin into the underlying muscle without traveling through the blood system for the purpose of increasing muscle energy. It is created by combining creatine with phosphoric acid in a cosmetically elegant vehicle suitable for topical use. Chondroitin sulfate and glucosamine can also be added. Topical creatine avoids the side effects of oral creatine supplements.Type: GrantFiled: April 30, 2002Date of Patent: May 4, 2004Inventor: David M. Stoll
-
Publication number: 20040081664Abstract: A method of producing a processed kava product involves using an extraction solvent, such as liquid CO2, to preferentially extract different kavalactones from the source material at different rates. By controlling the extraction parameters and stopping the extraction before all of the kavalactones have been extracted or allowing the extracted kavalactones to be preferentially precipitated in one or more collection environments, a processed kava product can be produced that has a kavalactone distribution profile that can differ substantially from that of the source material. As a result, roots from a less desirable kava cultivar can be used to produce a processed kava product which has a kavalactone distribution profile that is similar to that of a highly desired cultivar. The kava paste can be further processed to produce a dry flowable powder suitable for use in, e.g., a tableting formula. A rapid dissolve tablet formulation for use in the delivery of kavalactones and other botanicals is also disclosed.Type: ApplicationFiled: October 18, 2002Publication date: April 29, 2004Inventors: Robert Gow, John Pierce, Brian Pierce, William Birdsall
-
Publication number: 20040076688Abstract: The composition and process for preparing an anti-hemorrhoid composition which comprises providing a predetermined effective amount of natural substances of the genera Glycyrrhizae Radix, Testudinis Carapax, Cervi Parvum Cornu, Rhei Rhizoma, Ephedrae Herba, Natrii Sulfas, Moutan Radicis Cortx, Menthae Herba, Pinelliae Rhizoma, Pasoniae Radix, Acontii Tuber, Corni Fructus, Gypsum, Ginseng Radix, Cinnabaris, Talcum and Pelladendri Radix in an aqueous medium to form an initial mixture, extracting the initial mixture with water at a temperature of about 70°-80° C. for 1-2 hours to produce an aqueous mixture, filtering the aqueous mixture to produce a filtrate, and evaporating the filtrate to a moisture content of 30% to produce an extract which can be used as a treatment for hemorrhoid diseases.Type: ApplicationFiled: October 21, 2002Publication date: April 22, 2004Inventor: Chan Sik Park